SciELO - Scientific Electronic Library Online

 
vol.8 número4Osteomielites num Serviço de Pediatria GeralAbordagem do Delirium na Comunidade índice de autoresíndice de assuntosPesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Gazeta Médica

versão impressa ISSN 2183-8135versão On-line ISSN 2184-0628

Gaz Med vol.8 no.4 Queluz dez. 2021  Epub 01-Fev-2022

https://doi.org/10.29315/gm.v1i1.435 

Artigo Original

Repeated Demonstration on Inhaler Technique Impact: A Prospective Interventional Study

Impacto da Demonstração Repetida na Técnica Inalatória: Um Estudo Intervencional Prospetivo

Mafalda Filipa Casinhas Santos1 
http://orcid.org/0000-0001-7082-9373

Sara Mâncio dos Santos Limão Oliveira1 
http://orcid.org/0000-0002-4654-3700

Helena Margarida da Silva Morais Carrolo1 
http://orcid.org/0000-0002-6866-9515

Joana Manuela Soares Veríssimo Gil Pedro2 
http://orcid.org/0000-0001-9301-6797

David Mourão Marques Lito1 
http://orcid.org/0000-0002-1959-9629

1. Pediatric Service of Hospital Vila Franca de Xira, Vila Franca de Xira, Portugal.

2. Department of Pediatrics, Santa Maria Hospital - CHLN, Academic Medical Center of Lisbon, Lisboa, Portugal.


Abstract

Introduction:

Asthma continues to be the most frequent chronic condition in the pediatric population. Its control is affected by the misuse of inhaled medication. Inhaler technique demonstration to patients or caregivers seems to reduce error rate. This prospective interventional study was designed to prove that repeated demonstration of the inhaler technique to patients and caregivers improves patients` compliance and reduces error rate.

Methods:

One hundred patients were asked to demonstrate inhaler technique in sequential visits (51 patients demonstrated three times and 19 twice), filling a form by the responsible doctor, with “yes” or “no” registry according to several varies related to inhaler technique, mouth wash and spacer care.

Results:

Thirty patients were excluded from final analysis because they had only one observation. Mean age of 2.8 years (±1.9 years), 63% boys. During the study, 43 patients reduced error rate, 11 maintained the error and 16 had a correct technique since the beginning. Over successive assessments, the number of errors decreased substantially in inhaler technique (p-value 0.019), mouthwash (p-value 0.000) and spacer care (p-value 0.038). The only factors that reduced error rate were previous technique demonstration (p-value 0.003) and preceding inhaler-user (p-value 0.038).

Conclusion:

Correct inhaler technique demonstration has immediate positive impact on error reduction, which is amplified when successive demonstrations are performed by physicians.

Keywords: Administration, Inhalation; Asthma/therapy; Child; Metered Dose Inhalers

Resumo

Introdução:

A asma continua a ser a doença crónica mais frequente na população pediátrica. O seu controlo é condicionado negativamente pela utilização incorreta dos dispositivos para terapêutica inalatória. A demonstração da técnica de utilização correta a pais ou cuidadores parece estar associada a uma redução da taxa de erro. Este estudo intervencional prospetivo pretendeu confirmar a hipótese de que a demonstração repetida da técnica inalatória a pais e cuidadores tem impacto positivo na adesão dos doentes, reduzindo a taxa de erro.

Métodos:

Cem participantes expuseram a sua técnica inalatória em consultas sequenciais (51 em 3 consultas; e 19 em 2 consultas) com preenchimento de formulário pelo médico assistente com registo “sim” ou “não” em diferentes passos relacionados com a técnica inalatória, lavagem da boca e cuidados com a câmara.

Resultados:

Trinta doentes foram excluídos, pois só tinham uma observação. Idade média de 2,8 anos (±1,9 anos), 63% rapazes. Ao longo do estudo, 43 participantes reduziram a taxa de erro, 11 mantiveram o erro e 16 apresentaram uma técnica correta desde o início. Verificou-se uma redução substancial da taxa de erro da técnica inalatória (p-value 0,019), bem como da lavagem da boca (p-value 0,000) e da câmara expansora (p-value 0,038). Os únicos fatores associados à redução da taxa de erro foram a demonstração prévia da técnica (p-value 0,003) e o uso prévio do dispositivo inalatório (p-value 0,038).

Conclusão:

A demonstração da técnica inalatória correta por um médico teve um impacto positivo imediato na redução do erro, que foi amplificado pela realização de demonstrações sequenciais.

Palavras-chave: Administração por Inalação; Asma/tratamento; Criança; Inaladores Dosimetrados

Introduction

Asthma is one of the most frequent chronic conditions in the pediatric population, with a high social impact. It is responsible for substantial morbimortality, hospitalization and school/work absences.1-3 Recurrent wheezing and asthma are among the most common causes of pediatric emergency room department visits.2 In the United States, up to 20% of asthmatic children require emergency department visits annually.4 A large multicenter study revealed that asthma was the most common diagnosis of recurrent visitors and high frequency users (more than 4 visits per year) of the pediatric emergency department.5

Inhaler misuse by children and caregivers is an important factor for uncontrolled disease, thus technique review during medical appointments is of crucial importance.6 Since its introduction by 1960, it is known that inadequate inhaler technique results in suboptimal drug delivery to the lungs and, therefore, diminished drug response and clinical improvement.1,2,7 Less than 50% of children benefit from their inhaler therapy.2 Some studies report a high technique error rate even among physicians.2,3 Resnick revealed that only 26% of physicians perfectly demonstrated metered-dose inhalers (MDI) technique.8 They also showed that evaluation and demonstration of MDI technique at one medical appointment was insufficient to optimize patients’ performance.2,9 Technique demonstration by a qualified person, especially when repeatedly, seemed to be an important strategy for inhaler use improvement.10 The national clinical guideline for the management of asthma in Portugal recommends inhaler technique review at each appointment (Evidence A).11

The aim of this study was to understand if repeated demonstration of the inhaler technique to patients and caregivers by an assistant physician improves patients` compliance and reduces error rate. As secondary outcomes, we analyzed the influence of sociodemographic data on error rate. Questions about mouthwash after corticosteroid inhalation and spacer care were also addressed.

Material and Methods

We conducted a prospective interventional study on MDI plus spacer technique between 2013 and 2019, in a tertiary Hospital. One hundred MDI users were enrolled opportunistically as they attended medical appointments. The inclusion criteria were: being a frequent user of inhaled medications with spacer and bringing their inhaler device and spacer to the medical appointment. Patients with only one visit were excluded.

Caregivers were asked to demonstrate inhaler technique during three sequential visits (V1, V2 and V3). Periodicity of medical visits, according to symptom severity and control, was not changed.

Seven variables were analyzed and registered by the assistant physician as “yes” or “no” (Appendix 1) according to patient/caregiver performance (question 1 - Q1 to question 7 - Q7). Two additional questions about spacer care were addressed (question 8 - Q8 and 9 - Q9). Sociodemographic (parental age, education and marital status), disease (clinical diagnosis, familial and personal antecedents) and therapeutic (control and quick-relief medication) data were also collected on V1. The inhaler technique evaluation and the filling out the form was performed always by them same assistant physician.

Analysis was performed with Statistical Product and Service Solutions (SPSS 20.0.0) and R Statistics Software. We compared the total error number in Q1-Q7 during three sequential visits (V1-V3) and analyzed the influence of sociodemographic data on the variability of the obtained results. Fisher exact and Mann-Whitney tests were used to study the correlation between categorical variables and continuous variables, respectively. To analyze the role of inhaler technique demonstration on error rate over time, Fisher exact test was applied. We considered p-values < 0.05 to be significant.

RECORD checklist12) was verified during manuscript elaboration.13)

The study was approved by the Hospital Ethics Committee. Caregiver informed consent was obtained, and patient information was kept confidential.

Results

During the six-year study period, 100 patients were enrolled but only 51 were observed three times. Thirty patients were excluded since they had only one observation, so the impact of technique demonstration on error rate could not be analyzed (Fig. 1).

Figure 1: Distribution of the patients observed along the three sequential visits - One hundred patients were asked to demonstrate inhaler technique in sequential visits (51 patients demonstrated three times and 19 twice). Thirty patients were excluded from final analysis because they had only one observation. 

Patient sociodemographic, clinical and therapeutic data are listed in Table 1. The error rate of inhaler technique, mouthwash and spacer care over successive medical visits is shown in Table 2.

Among the 70 children studied, only 15.8% had previously demonstrated their inhaler technique to a physician.

During the study, 43 patients reduced error rate, 11 did not improve and 16 had a correct technique since the beginning.

The influence of inhaler technique demonstration on error rate over time was analyzed in the subgroup of 51 patients which completed the protocol. Over successive assessments, the number of errors decreased substantially in inhaler technique (p-value 0.019), mouthwash (p-value 0.000) and spacer care (p-value 0.038). However, Table 3 shows that relative distribution of different error types did not vary significantly over sequential visits (Fisher test p-value 0.42).

We attempted to establish a relationship between error rate and the different sociodemographic and clinical variables in Table 4. The only factors that reduced error rate were previous technique demonstration (p-value 0.003) and preceding inhaler-user (p-value 0.038). Nevertheless, there was only one child handling his own inhaler, which is insufficient evidence to draw conclusions.

Table 1: Patient sociodemographic, clinical and therapeutic data. 

Sample size (n) 100
Child’s age (years old; mean ± SD) 2.8 ± 1.9
Gender (n)
- Male 63
- Female 33
- Not registered 4
Diagnosis (n)
- Muli-trigger recurrent wheezing 33
- Viral-triggered recurrent wheezing 20
- Unspecified recurrent wheezing 25
- Asthma 22
Medication (n)
- Inhaled corticosteroids 50
- Inhaled corticosteroids + montelukast 24
- Inhaled corticosteroids + long-acting beta agonist (LABA) + short-acting beta agonist (quick-relief) 12
- Inhaled corticosteroids + LABA + montelukast + short-acting beta agonist (quick-relief) 5
- Short-acting beta agonist (quick-relief) 6
- Inhaled corticosteroids + Anti-histaminic 2
- Missing data 1
Child's caregiver marital status (n)
- Married 43
- Cohabiting 43
- Divorced 5
- Single 8
- Unknown 1
Caregiver responsible of inhaler (n)
- Mother 60
- Father 7
- Both parents 25
- Parents + Grandparents 2
- Parents + childcare worker 2
- Patient himself 1
- Unknown 3
Mother’s age (years old; mean ± SD) 33.4 ± 5.8
Father’s age (years old; mean ± SD) 34.9 ± 6.2
Mother education (n)
- Primary 45
- High School 40
- College 14
- Student 1
Father education (n)
- Primary 45
- High School 35
- College 9
- Unknown 11
Familiar history of atopy (n)
- yes 57
- no 40

Table 2: Error rate in inhaler technique, mouthwash and spacer care. 

Frequency (%)
  V1 V2 V3
INHALER TECHNIQUE
- 0 errors 64.7 80.4 90.2
- 1 error 27.5 17.6 9.8
- 2 errors 2 3 0
- 3 errors 5.9 0 0
- Mean number of errors (s.e.m.) 0.49 (0.11) 0.22 (0.06) 0.10 (0.04)
p-value (Fisher test): 0.019
MOUTHWASH (IF CORTICOTHERAPY)
- 0 errors (yes) 64 92 96
- 1 error (no) 36 8 4
- Mean number of errors (s.e.m.) 0.36 (0.07) 0.08 (0.04) 0.04 (0.03)
p-value (Fisher test): 0.000
SPACER CARE
- 0 errors 73.5 91.8 91.8
- 1 error 20.4 6.1 8.2
- 2 errors 61 2 0
- 3 errors 59 0 0
- Mean number of errors (s.e.m.) 0.33 (0.08) 0.10 (0.05) 0.08 (0.04)
p-value (Fisher test): 0.038

Legend: s.e.m. - standard error of the mean.

Table 3: Frequency of mistakes observed during the three clinical assessments. 

Error Type Fraction of children/caregiver (%) Frequency within assessment (%)
V1 V2 V3 V1 V2 V3
Correct child position 6.0 4.3 1.9 4.4 9.9 8.2
Remove the cap 1.0 0.0 0.0 0.7 0.0 0.0
Shake inhaler 28.0 10.0 1.9 20.6 23.0 8.2
Mask correctly adapted 4.0 1.4 1.9 2.9 3.2 8.2
No air leakage 5.0 1.4 0.0 3.7 3.2 0.0
Press inhaler canister 0.0 0.0 0.0 0.0 0.0 0.0
Counting 10 seconds while breathing normally 12.0 2.9 1.9 8.8 6.7 8.2
Wait at least 30 seconds to repeat 7.1 7.1 3.8 5.2 16.4 16.4
Wash the mouth at the end (corticosteroids) 43.0 7.4 4.0 31.6 17.1 17.2
Hand wash the spacer 10.3 1.5 0.0 7.6 3.4 0.0
Air dry the spacer 19.6 7.4 7.8 14.5 17.1 33.6

Table 4: Relation between sociodemographic data and errors. 

  p-value
  ≥ 1 error in inhalation technique no mouthwash ≥ 1 error in spacer care
Age at the beginning of the study (Wilcox) 0.144 0.714 0.779
Gender (Fisher) 0.383 0.263 0.676
Diagnosis (Fisher) 0.424 0.994 0.926
Mother age (Wilcox) 0.350 0.922 0.548
Father age (Wilcox) 0.581 0.569 0.793
Mother education (Fisher) 0.263 0.412 0.670
Father education (Fisher) 0.711 0.746 0.310
Parents’ marital status (Fisher) 0.901 0.590 0.624
Family history (Fisher) 0.832 0.388 0.805
Who manage inhaler device (Fisher) 0.037 0.935 0.242
Medication drugs (Fisher) 0.908 0.665 0.819
Duration of medication (Wilcox) 0.094 0.429 0.650
Previous demonstration of inhaler technique (Fisher) 0.003 0.569 1
Time passed since last demonstration (Wilcox) 0.340 0.127 0.298

Discussion

Only half of the patients completed the three-phase evaluation because patients do not usually take their inhalation equipment to medical visits, even if advised to. Besides that, some patients/caregivers did not even know their specific therapeutic plan, offered in written at each appointment. An inappropriate inhaler technique is a major obstacle to achieving good asthma control and may lead to overmedication and raised healthcare costs.1,2) Uncontrolled disease increases health resources consumption through more unscheduled clinic visits, emergency department visits and hospital admissions.3,7 It may also lead to frustration and worse therapeutic compliance.3

Error rate is higher in the first evaluation, except in those who had previously demonstrated their technique. In our study, only a small percentage of patients revealed a correct inhaler technique since the beginning (16.0%). In a similar study in North Carolina, Sleath observed that only 8.1% of children managed MDI correctly.7

The most frequent mistakes described by Sleath were related to (1) exhaling normally before and (2) holding their breath for at least 10 seconds after inhaling.7 According to Fink, the most common errors were (1) hand-breath coordination, (2) low inspiratory flow, (3) too fast inspiratory flow and (4) inadequate shaking. In pediatric population, the use of a spacer allows to overcome some of these issues.3) In accordance with the literature, the most frequent mistakes observed in our study were (1) inadequate shaking of the inhaler, (2) not counting 10 seconds while breathing normally and (3) incorrect spacer cleaning. In addition, a quarter of the patients did not shake their inhaler device in advance and almost half of the patients taking corticosteroids did not wash their mouth after inhalation.

In our study, there was no correlation between error rate and the different sociodemographic variables analyzed. However, other studies reported an association with age, education status, previous inhaler instruction, comorbidities and socioeconomic status. A significant association was found between inhaler error and poor disease outcomes (exacerbations) and greater health-economic burden.14,15

Correct inhaler technique demonstration has immediate positive impact on error reduction, which is amplified when successive demonstrations are performed by physicians. Most authors suggest careful instruction, observation of technique, instruction leaflets and audio-visual support.1,3,9,16

Patient’s MDI technique is better when verbal information is accompanied by demonstration with a placebo inhaler or when compared to an instruction leaflet alone.2,9 Even with short appointment times, evidence suggests the importance of inhaler technique demonstration at each visit to improve respiratory health outcomes. During medical appointments, symptoms and medication are revised, but the physician has hardly enough time to adequately educate the patient and caregivers.3,7 Fink considered that management of chronic airway disease depends 10% on medication and 90% on education.3

The study sample was significantly reduced over time because patients have frequently forgotten to take their devices to medical appointments. Furthermore, the short follow-up period represents a limitation for assessing the sustainability of error rate reduction. Time between appointments was not standardized and the study relied on a random sample.

Conclusion

We conclude that at least one demonstration of correct inhaler technique reduces the number of observed errors. Even during short medical appointments, technique review takes only a few minutes and represents a critical improvement in patient’s technique and, presumably, in disease control.17,18 The impact of inhaler technique has been subjugated by clinicals, patients and caregivers, and can even be the limitative factor for an adequate control of disease.

This study reinforces the need of patient education and technique review at each medical appointment, using attractive leaflet to engage the patient, even the younger ones.

References

1. Sanchis J, Gich I, Pedersen S; Aerosol Drug Management Improvement Team (ADMIT). Systematic Review of Errors in Inhaler Use: Has Patient Technique Improved Over Time? Chest. 2016;150:394-406. doi: 10.1016/j.chest.2016.03.041. [ Links ]

2. Minai BA, Martin JE, Cohn RC. Results of a physician and respiratory therapist collaborative effort to improve long-term metered-dose inhaler technique in a pediatric asthma clinic. Respir Care. 2004;49:600-5. [ Links ]

3. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50:1360-75. [ Links ]

4. Dondi A, Calamelli E, Piccinno V, Ricci G, Corsini I, Biagi C, et al. Acute Asthma in the Pediatric Emergency Department: Infections Are the Main Triggers of Exacerbations. Biomed Res Int. 2017;2017:9687061. doi: 10.1155/2017/9687061. [ Links ]

5. Alpern ER, Clark AE, Alessandrini EA, Gorelick MH, Kittick M, Stanley RM, et al; Pediatric Emergency Care Applied Research Network (PECARN). Recurrent and high-frequency use of the emergency department by pediatric patients. Acad Emerg Med. 2014;21:365-73. doi: 10.1111/acem.12347. [ Links ]

6. Chike-Harris KE, Kinyon-Munch K. Asthma 101: Teaching children to use metered dose inhalers. Nursing. 2019;49:56-60. doi: 10.1097/01.NURSE.0000552703.80996.43. [ Links ]

7. Sleath B, Ayala GX, Gillette C, Williams D, Davis S, Tudor G, et al. Provider demonstration and assessment of child device technique during pediatric asthma visits. Pediatrics. 2011;127:642-8. doi: 10.1542/peds.2010-1206. [ Links ]

8. Resnick DJ, Gold RL, Lee-Wong M, Feldman BR, Ramakrishnan R, Davis WJ. Physicians' metered dose inhaler technique after a single teaching session. Ann Allergy Asthma Immunol. 1996;76:145-8. doi: 10.1016/S1081-1206(10)63413-8. [ Links ]

9. Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al; Aerosol Drug Management Improvement Team. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006;100:1479-94. doi: 10.1016/j.rmed.2006.01.008. [ Links ]

10. Frémont A, Abou Taam R, Wanin S, Lebras MN, Ollier V, Nathanson S, et al. Cartoons to improve young children's cooperation with inhaled corticosteroids: A preliminary study. Pediatr Pulmonol. 2018;53:1193-9. doi: 10.1002/ppul.24070. [ Links ]

11. Direção-Geral da Saúde. Monitorização e Tratamento para o Controlo da Asma na Criança, no Adolescente e no Adulto: Norma 006/2018 da Direcção-Geral da Saúde. Lisboa: DGS;2018. [ Links ]

12. Nie X, Peng X. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. Chin J Evid Based Med. 2017;17: 475-87. [ Links ]

13. Benchimol EI, Smeeth L, Guttmann A, Harron K, Hemkens LG, Moher D, et al. Das RECORD-Statement zum Berichten von Beobachtungsstudien, die routinemäßig gesammelte Gesundheitsdaten verwenden. Z Evid Fortbild Qual Gesundhwes. 2016;115-6:33-48. doi: 10.1016/j.zefq.2016.07.010. [ Links ]

14. Usmani OS, Lavorini F, Marshall J, Dunlop WC, Heron L, et al. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018;19:10. doi: 10.1186/s12931-017-0710-y.15. [ Links ]

15. Barbara S, Kritikos V, Bosnic-Anticevich S. Inhaler technique: does age matter? A systematic review. Eur Respir Rev. 2017;26:170055. doi: 10.1183/16000617.0055-2017. [ Links ]

16. Nicola M, Elberry A, Sayed O, Hussein R, Saeed H, Abdelrahim M. The Impact of Adding a Training Device to Familiar Counselling on Inhalation Technique and Pulmonary Function of Asthmatics. Adv Ther. 2018;35:1049-58. doi: 10.1007/s12325-018-0737-6. [ Links ]

17. Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, et al. Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes. J Allergy Clin Immunol Pract. 2017;5:1071-81.e9. doi: 10.1016/j.jaip.2017.01.004. [ Links ]

18. Deerojanawong J, Promsaka na Sakolnakorn V, Prapphal N, Hanrutakorn C, Sritippayawan S. Evaluation of metered-dose inhaler administration technique among asthmatic children and their caregivers in Thailand. Asian Pac J Allergy Immunol. 2009;27:87-93. [ Links ]

Responsabilidades Éticas

Conflitos de Interesse: Os autores declaram a inexistência de conflitos de interesse na realização do presente trabalho.

Fontes de Financiamento: Não existiram fontes externas de financiamento para a realização deste artigo.

Confidencialidade dos Dados: Os autores declaram ter seguido os protocolos da sua instituição acerca da publicação dos dados de doentes.

Proteção de Pessoas e Animais: Os autores declaram que os procedimentos seguidos estavam de acordo com os regulamentos estabelecidos pelos responsáveis da Comissão de Investigação Clínica e Ética e de acordo com a Declaração de Helsínquia revista em 2013 e da Associação Médica Mundial.

Proveniência e Revisão por Pares: Não comissionado; revisão externa por pares.

Ethical Disclosures

Conflicts of Interest: The authors have no conflicts of interest to declare.

Financing Support: This work has not received any contribution, grant or scholarship

Confidentiality of Data: The authors declare that they have followed the protocols of their work center on the publication of data from patients.

Protection of Human and Animal Subjects: The authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki as revised in 2013).

Provenance and Peer Review: Not commissioned; externally peer reviewed.

Received: March 05, 2021; Accepted: December 17, 2021; Published: December 31, 2021

Mafalda Filipa Casinhas Santos #091;mafaldacasinhassantos@gmail.com] Hospital Vila Franca de Xira, Estrada Carlos Lima Costa, Nº2, 2600-009 Vila Franca de Xira, Portugal ORCID iD: 0000-0001-7082-9373

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License